Profile
ONCO VRTX REGN SGEN ARGX ALNY
Company Name Onconetix, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $6.11M $118.67B $73.71B $43.15B $38.90B $32.36B
Employees 0.01K 6.10K 15.11K 3.26K 1.15K 2.23K
CEO Dr. Ralph Schiess Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
ONCO VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 3 4 3 1 1
Quant Rating Sell Neutral Buy Neutral Strong Sell Strong Sell
Trading
ONCO VRTX REGN SGEN ARGX ALNY
Last Close $0.42 $480.33 $696.02 $228.74 $647.49 $251
High 52 $6.2 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.07 $392.81 $663.86 $228.74 $356.01 $143.31
Price vs. 52 Week High -93.23 % -7.05 % -42.08 % 0 % -3.61 % -15.42 %
Price vs. 52 Week Low 500 % 22.28 % 4.84 % 0 % 81.87 % 75.14 %
Total Return
ONCO VRTX REGN SGEN ARGX ALNY
1 Month Return -22.22 % 12.26 % 1.2 % 0 % 0.02 % -5.28 %
3 Month Return -62.83 % 6.65 % -6.51 % 0 % 8.5 % 1.7 %
6 Month Return 150.3 % -1.19 % -41.28 % 0 % 23.21 % -10.09 %
9 Month Return 214.61 % 8.67 % -29.97 % 0 % 81.54 % 67.76 %
YTD Return -33.33 % 19.28 % -2.29 % 0 % 5.28 % 6.67 %
1 Year Return 0 % 14.47 % -26.95 % 0 % 61.89 % 62.21 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ONCO VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) -2.29 % -1.65 % 5.37 % -2.27 % -2.22 % -0.24 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - - - - -
Growth
ONCO VRTX REGN SGEN ARGX ALNY
Asset Growth 232.64 % 25.23 % 13.23 % -1.21 % 44.93 % 7.99 %
Gross Profit Growth -16593.79 % 9.64 % 6.49 % 22.93 % 190.7 % 74.75 %
Revenue Growth - 10.51 % 7.76 % 24.65 % 198.56 % 76.23 %
Revenue 3 Year - 60.36 % 55.67 % 91.56 % 2071.96 % 241.5 %
Revenue 5 Year - 219.55 % 110.3 % 215.48 % 3041.46 % 1865.57 %
Revenue 10 Year - 610.45 % 549.62 % 494.04 % 9009.53 % 1810.11 %
EBIT Growth -167.29 % 0 % -14.6 % 10.13 % 40.94 % 64.06 %
Net Income Growth -178.76 % 8.96 % -8.87 % 9.51 % 58.42 % 61.08 %
Net Income 3 Yeari Growth Per Share -1410.19 % 34.59 % 13.48 % -763.59 % 64.01 % 52.78 %
Net Income 5 Yeari Growth Per Share -2838.86 % 70.33 % 74.02 % -276.93 % -143.65 % 53.44 %
Net Income 10 Yeari Growth Per Share -2838.86 % 809.6 % 871.12 % -624.16 % -857 % -143.14 %
Operating Income Growth -167.29 % 0 % -14.6 % 10.13 % 40.94 % 64.06 %
Operating Cash Flow Growth (CFG) -56.12 % -14.35 % -8.39 % 9.07 % 51.28 % 119.24 %
Operating 3 Year CFG -406.84 % 9.63 % 76.95 % -147.99 % 21.71 % 115.59 %
Operating 5 Year CFG -962.76 % 174.78 % 125.17 % -195.86 % -329.63 % 114.91 %
Operating 10 Year CFG -962.76 % 6084.35 % 713.56 % -2622.09 % -1280.2 % 174.76 %
EPS Growth -100.92 % 8.33 % -8.54 % 10.81 % 60.46 % 62.15 %
EPS Diluted Growth -100.92 % 8.35 % -9.03 % 10.81 % 60.46 % 62.15 %
Book Value Per Share 106.09 % 25.58 % 15.03 % -9.83 % 38.53 % -35.86 %
Share Holder 3 Year Equity Growth Per Share 699.77 % 104.06 % 137.56 % 33.72 % 94.42 % -119.99 %
Share Holder 5 Year Equity Growth Per Share 531.16 % 291.14 % 219.1 % 220.81 % 318.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share 531.16 % 1030.79 % 1286.9 % 691.19 % 3654.06 % -140.22 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth - 44.1 % 0.06 % -23.28 % 60.95 % 103.19 %
Free Cash Flow Growth -56.59 % -16.47 % -17.11 % 3.67 % 51.98 % 106.84 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023 31 Dec 2023
Profitability
ONCO VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM -41.22 % 86.09 % 84.47 % 72.37 % 86.82 % 85.62 %
Return on Assets TTM -83.34 % -2.38 % 11.69 % -11.76 % -2.13 % -6.56 %
Return on Equity TTM -126.11 % -3.28 % 14.77 % -16.53 % -2.75 % 905.33 %
Return on Capital Employed TTM -56.66 % -1.3 % 10.89 % -16.87 % -8.98 % -5.79 %
Net Income Per EBT TTM 99.73 % -215.53 % 92.32 % 100.55 % 167.72 % 73.71 %
EBT Per Ebit TTM 204.91 % -100.69 % 118.85 % 94.01 % 15.76 % 213.34 %
EBIT Per Revenue TTM -1349.92 % -2.24 % 28.32 % -36.09 % -17.08 % -7.87 %
Cash Flow To Debt Ratio TTM -138.9 % -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Receivables Turnover TTM 19.08 6.84 2.29 1.98 3.45 5.55
Payables Turnover TTM 0.64 3.71 2.79 1.54 1.06 3.66
Inventory Turnover TTM 21.68 1.27 0.71 0.65 0.91 4.12
Fixed Asset Turnover TTM 815.67 % 425.82 % 308.76 % 256.83 % 6116.64 % 323.99 %
Asset Turnover TTM 3.02 % 48.84 % 37.61 % 34.46 % 47.09 % 53.02 %
Operating Cash Flow Per Share TTM -10.63 -1.91 41.08 -1.12 -2.42 -0.06
Free Cash Flow Per Share TTM -6 -3.07 33.43 -1.62 -3.52 -0.33
Cash Per Share TTM 26.15 % 2375.11 % 16647.4 % 657.5 % 5163.05 % 2095.42 %
Operating Cash Flow Sales Ratio TTM -742.54 % -4.48 % 31.13 % -16.85 % -6.44 % -0.37 %
Free Cash Flow Operating Cash Flow Ratio TTM 56.41 % 160.43 % 81.38 % 144.14 % 145.12 % 512.38 %
Cash Flow Coverage Ratios TTM -138.9 % -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Price To Free Cash Flows Ratio TTM -0.78 -150.15 20.49 -141.85 -184.15 -759.92
Price To Operating Cash Flows Ratio TTM -0.04 -241.56 16.69 -203.89 -264.28 -3867.6
Price Cash Flow Ratio TTM -0.04 -241.56 16.69 -203.89 -264.28 -3867.6
Income Statement (TTM)
ONCO VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $1.23B $2.25B
Gross Profit $-0B $9.49B $12.23B $1.55B $1.11B $1.92B
Gross Profit Ratio -1927.93% 86.11% 86.13% 79.1% 90.39% 85.62%
EBITDA $-0.04B $0.49B $5.32B $-0.62B $-0.22B $-0.18B
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.3B $-0.28B
EPS Diluted -2.19 -2.08 38.34 -3.3 -5.16 -2.16
Balance Sheet (MRQ)
ONCO VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.04B $0.02B $0B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $0.44B $4.17B
Total Equity $0.07B $16.41B $29.35B $2.8B $4.1B $0.07B
Total Investments $0.03B $6.65B $6.52B $1.42B $1.18B $1.73B
Total Debt $0.01B $1.75B $2.7B $0.04B $0.02B $1.3B
Total Assets $0.09B $22.53B $37.76B $3.67B $4.54B $4.24B
Cash Flow Statement (TTM)
ONCO VRTX REGN SGEN ARGX ALNY
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.43B $-0.28B
Inventory $-0B $-0.52B $-0.62B $-0.23B $-0.08B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.42B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.04B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.78
AAPG 21.3
ABCL AbCellera Biologics Inc. 3.04
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.765
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.395
ABPWW 0.041
ABSI Absci Corporation 4.94
ABUS Arbutus Biopharma Corporation 3.415
ABVC ABVC BioPharma, Inc. 0.68
ABVX Abivax SA American Depositary Shares 7.98
ACAD ACADIA Pharmaceuticals Inc. 19.955
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.975
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.3888
ACHV Achieve Life Sciences, Inc. 3.17
ACIU AC Immune SA 2.64
ACLX Arcellx, Inc. 63.5
ETFs With Exposure to ONCO
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 190.465
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.13
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.14
VEMPX Vanguard Extended Market Index InstlPlus 0 368.03
Unlock